drug · unknown
galinpepimut-S
Phase 3updated 3mo agoby $SLS SELLAS Life Sciences Group, Inc.🔗 ChEMBL
Phase 3community read0 votes
Unknown drug with a maximum clinical stage of Phase 3 (across all indications), with 6 investigational indications.
targets
Wilms tumor protein
all catalysts(0)
nothing on the calendar yet
Trials studying galinpepimut-S
- —Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS
- phase3Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
- phase2WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
- phase2Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
- phase2Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy
- phase2WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that